BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
Business & Finance

Fauci expects tens of millions of coronavirus vaccine doses at start of 2021

  • Fauci said he has not seen any pressure from the White House to announce a vaccine close to the Nov.
  • He added that regulators have promised "they are not going to let political considerations interfere" with the approval of a COVID-19 vaccine.
Published Updated
By

WASHINGTON: Drugmakers will likely have tens of millions of doses of a coronavirus vaccine in the early part of next year, with production ramping up so that it hits a billion doses by the end of 2021, Anthony Fauci, the top US government official on infectious diseases, said in a Reuters interview on Wednesday.

Fauci said he has not seen any pressure from the White House to announce a vaccine close to the Nov. 3 election in the hopes of boosting President Donald Trump's re-election chances.

He added that regulators have promised "they are not going to let political considerations interfere" with the approval of a COVID-19 vaccine and that "safety and efficacy" will be primary considerations.

Fauci's interview with Reuters came on the same day Trump said in an interview with Fox News that the virus is "going away. It will go away like things go away."

Fauci offered a more mixed assessment, saying some parts of the country had done well in containing the spread of the virus, while others were "on fire."

He characterized the varying responses to the virus as "disjointed" - owing to the size and the diversity of the nation.

Fauci said he hoped the pandemic would be under greater control by the end of the year, when he expects a vaccine to be available.

While Fauci stressed that there is a "middle ground" in which the country can prudently reopen, he said the politicization of mask-wearing was detrimental to the fight against the virus.

Comments

Comments are closed for this article.